Cargando…

The Authors Respond

Detalles Bibliográficos
Autores principales:	Le, Quang A., Delevry, Dimittri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2020
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391098/ https://www.ncbi.nlm.nih.gov/pubmed/32105177 http://dx.doi.org/10.18553/jmcp.2020.26.3.335

Ejemplares similares

Cost-Effectiveness of Treatment Strategies with Biologics in Accordance with Treatment Guidelines for Ankylosing Spondylitis: A Patient-Level Model
por: Le, Quang A., et al.
Publicado: (2020)

THE AUTHORS RESPOND
por: Roth, Joshua A., et al.
Publicado: (2020)

The Authors Respond
por: Carlson, Josh J., et al.
Publicado: (2018)

The Authors Respond
por: Simpson, Mindy L., et al.
Publicado: (2020)

The Authors Respond
por: Sherrill, Christina H., et al.
Publicado: (2020)

The Authors Respond
por: Touchette, Daniel R., et al.
Publicado: (2020)

The Authors Respond
por: Traini, Eugenio, et al.
Publicado: (2022)

The Authors Respond
por: Xie, Jipan, et al.
Publicado: (2012)

The Authors Respond
por: Hain, Jocelyn
Publicado: (2010)

The Authors Respond:
por: Clay, Patrick
Publicado: (2007)

The Authors Respond
por: Miller, Ross M., et al.
Publicado: (2012)

The Authors Respond
por: Barlow, Stephen
Publicado: (2010)

THE AUTHORS RESPOND
por: Guzauskas, Gregory F, et al.
Publicado: (2021)

Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
por: Paller, Amy S., et al.
Publicado: (2022)

The authors respond to criticisms of their model parameters
por: Fisman, David, et al.
Publicado: (2022)

The authors respond to comments from Vermaak and Stahlbrand
por: Nakagawa, Hiroaki, et al.
Publicado: (2021)

The authors respond to: “Delayed discharge and frailty, delirium and functional decline”
por: Jerath, Angela, et al.
Publicado: (2021)

Re: Comments on “Neuromuscular Ultrasonography of Cranial Nerves”: The Authors Respond
por: Tawfik, Eman A., et al.
Publicado: (2017)

The authors respond to “Concerns about subgroup analyses and reason for stopping remdesivir trial”
por: Murthy, Srinivas
Publicado: (2022)

The authors respond to letters on using prescribed psychostimulants to treat stimulant use disorder
por: Palis, Heather N., et al.
Publicado: (2023)

The Author Respond
por: Choi, Jong Sang
Publicado: (2008)

Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis
por: Simpson, Eric L., et al.
Publicado: (2021)

RE: Comments on "Unilateral Reversible Posterior Leukoencephalopathy Syndrome after Coiling of an Aneurysm": The Authors Respond
por: Huijgen, Willemijn, et al.
Publicado: (2014)

Re: Comments on “Pure or Complex Hereditary Spastic Paraplegia Type 4?”: The Authors Respond
por: Yang, Jiwon, et al.
Publicado: (2019)

Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective
por: de Bruin-Weller, Marjolein, et al.
Publicado: (2021)

This Issue’s Authors and Panel Respondents
Publicado: (2011)

This Issue’s Authors & Panel Respondents
Publicado: (2004)

This Issue’s Authors & Panel Respondents
Publicado: (2003)

This Issue’s Authors & Panel Respondents
Publicado: (2002)

This Issue’s Authors & Panel Respondents
Publicado: (2007)

This Issue’s Authors & Panel Respondents
Publicado: (2007)

This Issue’s Authors & Panel Respondents
Publicado: (2009)

This Issue’s Authors & Panel Respondents
Publicado: (2008)

The authors respond: monkeypox presentations
por: Brady, William J., et al.
Publicado: (2023)

The Editors Respond
por: Curtiss, Frederic R.
Publicado: (2010)

Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis
por: Yosipovitch, Gil, et al.
Publicado: (2021)

Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study
por: Kimball, Alexa B., et al.
Publicado: (2023)

Responder analyses for anti-amyloid immunotherapies for Alzheimer’s disease: a paradigm shift by regulatory authorities is urgently needed
por: Salemme, Simone, et al.
Publicado: (2023)

This Issue’s Authors, Contributors, & Panel Respondents
Publicado: (2005)

Re: Comments on “Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19”: The Authors Respond
por: Kang, Kyusik, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lkmugjmuinflj0io397nrkftru